Gilead Sciences 8-K 2006
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
April 18, 2006
GILEAD SCIENCES, INC.
(Exact name of registrant as specified in its charter)
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA
(Address of principal executive offices)
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
SECTION 2 FINANCIAL INFORMATION
Item 2.02 Results of Operations and Financial Condition
On April 18, 2006, Gilead Sciences, Inc. (the Company), a Delaware corporation, issued a press release announcing the financial results for the quarter ended March 31, 2006. A copy of the press release is filed as Exhibit 99.1 to this report.
Each non-GAAP financial measure reflected in the earnings press release is included because the Companys management uses this information to better understand the comparative operating performance of the Company. For the quarter ended March 31, 2006, these adjustments included $23.5 million of after-tax share-based employee compensation expense from the impact of the adoption of the Financial Accounting Standards Boards Statement No. 123 (revised 2004), Share Based Payment. Consequently, excluding these transactions from the Companys results provides users of the financial statements an important insight into the Companys results and related trends that affect the Companys core business.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 18, 2006